ArticleTherapeutic advances in medical oncology2020

Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK - A16037).

Susana Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.